Skip to main content

Table 2 Concordance of Elecsys CSF immunoassay biomarkers and biomarker ratios with amyloid PET

From: The cerebrospinal fluid biomarker ratio Aβ42/40 identifies amyloid positron emission tomography positivity better than Aβ42 alone in a heterogeneous memory clinic cohort

CSF biomarker

AUC (95% CI)

Cut-off

Sensitivity

Specificity

Aβ42

0.78 (0.68−0.88)

Pre-defined

< 1000 pg/mL

0.93

0.57

Youden index

< 1070 pg/mL

1.00

0.57

pTau181

0.82 (0.73−0.90)

Pre-defined

> 27 pg/mL

0.69

0.80

Youden index

> 22 pg/mL

0.83

0.71

tTau

0.78 (0.68−0.87)

Pre-defined

> 300 pg/mL

0.63

0.73

Youden index

> 241 pg/mL

0.87

0.63

pTau181/Aβ42 ratio

0.88 (0.81−0.95)

Pre-defined

> 0.024

0.96

0.69

Youden index

> 0.027

0.96

0.76

tTau/Aβ42 ratio

0.87 (0.80−0.95)

Pre-defined

> 0.28

0.92

0.69

Youden index

> 0.33

0.91

0.78

Aβ42/40 ratio

0.90 (0.83−0.97)

Pre-defined

NA

NA

NA

Youden index

< 0.048

0.94

0.82

pTau181/(Aβ42/40) ratio

0.87 (0.80−0.94)

Pre-defined

NA

NA

NA

Youden index

> 447

0.92

0.76

tTau/(Aβ42/40) ratio

0.86 (0.79−0.94)

Pre-defined

NA

NA

NA

Youden index

> 5164

0.94

0.73

  1. amyloid beta, AUC area under the curve, CI confidence interval, CSF cerebrospinal fluid, NA not applicable, PET positron emission tomography, pTau181 phosphorylated tau 181, tTau total tau